Blue Owl Capital OWL Q1 2026 Earnings EPS Surpasses Estimates Signaling Steady Momentum RWAY Q1 2026 Earnings EPS Falls Short of Analyst Expectations CBIO Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Progresses BEEP Q1 2026 Earnings Slight EPS Beat Amid Revenue Uncertainty and Stock Decline Penumbra PEN Q1 2026 Earnings EPS Misses Estimates by 245 as Revenue Details Remain Unclear CLFD Q1 2026 Earnings Narrower Loss than Expected Drives Stock Uptick